摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

8-bromo-1,3-dimethyl-7-propargyl-3,7-dihydro-1H-purine-2,6-dione | 115919-19-2

中文名称
——
中文别名
——
英文名称
8-bromo-1,3-dimethyl-7-propargyl-3,7-dihydro-1H-purine-2,6-dione
英文别名
7-(prop-2-yn-1-yl)-8-bromo-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione;8-bromo-1,3-dimethyl-7-(prop-2-yn-1-yl)-3,7-dihydro-1H-purine-2,6-dione;8-bromo-1,3-dimethyl-7-(prop-2-yn-1-yl)-1H-purine-2,6(3H,7H)-dione;7-propargyl-8-bromo-1,3-dimethyl-3,7-dihydropurine-2,6-dione;Qxhdcpfrmxskgn-uhfffaoysa-;8-bromo-1,3-dimethyl-7-prop-2-ynylpurine-2,6-dione
8-bromo-1,3-dimethyl-7-propargyl-3,7-dihydro-1H-purine-2,6-dione化学式
CAS
115919-19-2
化学式
C10H9BrN4O2
mdl
——
分子量
297.111
InChiKey
QXHDCPFRMXSKGN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    189-191 °C
  • 沸点:
    461.6±55.0 °C(predicted)
  • 密度:
    1.66±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    58.4
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    8-bromo-1,3-dimethyl-7-propargyl-3,7-dihydro-1H-purine-2,6-dione一水合肼 作用下, 以 乙醇 为溶剂, 反应 3.0h, 以82%的产率得到8-Hydrazinyl-1,3-dimethyl-7-prop-2-ynylpurine-2,6-dione
    参考文献:
    名称:
    New [f]-Fused Theophyllines: A Simple One-Step Synthesis of the Pyrimido[2,1-f]purine System via 8-Azidopurines
    摘要:
    描述了一种从7-(2-烯基)-或7-(2-炔基)-8-叠氮茶碱出发制备新型四氢和六氢嘧啶并[2,1-f]嘌呤的方法。
    DOI:
    10.1055/s-1989-27355
  • 作为产物:
    参考文献:
    名称:
    作为新型 DPP-4 抑制剂的利格列汀的 1,2,3-三唑类似物的合成:DFT,分子对接方法
    摘要:
    摘要 如本文所述,从 CuI 催化的N-炔丙基嘌呤和几种芳基叠氮化物之间的 1,3-偶极环加成反应合成一些新型 1,2,3-三唑基利格列汀衍生物。进一步评估了所有这些新化合物的体外二肽基肽酶 4 (DPP-4) 活性和化合物 8-bromo-1,3-dimethyl-7-((1-(3-(trifluoromethyl)phenyl)-1 H -1,2,3-triazol-4-yl)methyl)-1 H -purine-2,6(3 H ,7 H )-dione, 7-(but-2-yn-1-yl)-1 ,3-二甲基-8-(4-((1-(3-(三氟甲基)苯基)-1H-1,2,3-三唑-4-基)甲基)哌嗪-1-基) -1H-嘌呤-2,6(3 H ,7 H )-二酮和 7-(but-2-yn-1-yl)-8-(4-((1-(3,5-二氯苯基)-1H -1,2,3-triazol-4-yl)met
    DOI:
    10.1134/s1068162023030214
点击查看最新优质反应信息

文献信息

  • Synthesis and Biological Evaluation of Novel Fused [1,2,3]Triazolo[4',5':3,4] pyrrolo[2,1-f]purines as Potent Anti-Proliferative Agents
    作者:E. Ramya Sucharitha、N. Satheesh Kumar、M. Ravinder、N. Vasudeva Reddy、Sirassu Narsimha
    DOI:10.1134/s1068162021040208
    日期:2021.7
    Abstract In search of the best anticancer agents, a series of novel fused [1,2,3]triazolo[4',5':3,4] pyrrolo[2,1-f]purine derivatives in one vessel was synthesized using 8-bromo-1,3-dimethyl-7-(prop-2-yn-1-yl)-1H-purine-2,6(3H,7H)-dione and various arylazides. The newly synthesized derivatives were evaluated for their in vitro anti-proliferative activity against four human cancer cell lines (MCF-7
    摘要 在寻找最佳抗癌剂,一系列新的稠合的[1,2,3]三唑并[4' ,5' :3,4]吡咯并[2,1- ˚F使用8-]在一个容器中的嘌呤生物的合成-1,3-二甲基-7-(prop-2-yn-1-yl)-1H-purine-2,6(3 H ,7 H )-dione 和各种芳基叠氮化物。评估了新合成的衍生物对四种人类癌细胞系(MCF-7、HeLa、A-549 和 U-87MG)的体外抗增殖活性。3-(3,5-二氯苯基)-5,7-二甲基-7,10-二氢-[1,2,3]三唑并[4',5':3,4]吡咯并[2,1- f ]嘌呤-6,8(3 H ,5 H )-二酮和 5,7-二甲基-3-(4-硝基苯基)-3,10-二氢-[1,2,3]三唑并[4',5':3.4 ]pyrrolo[2,1 - f ]purine-6,8 (5 H ,7H )-二酮对 MCF-7 和 A-549 显示出更强的活性,IC
  • New 8-aminoalkyl derivatives of purine-2,6-dione with arylalkyl, allyl or propynyl substituents in position 7, their 5-HT1A, 5-HT2A, and 5-HT7 receptor affinity and pharmacological evaluation
    作者:Grażyna Chłoń-Rzepa、Paweł Żmudzki、Grzegorz Satała、Beata Duszyńska、Anna Partyka、Dagmara Wróbel、Magdalena Jastrzębska-Więsek、Anna Wesołowska、Andrzej J. Bojarski、Maciej Pawłowski、Paweł Zajdel
    DOI:10.1016/s1734-1140(13)70960-5
    日期:2013.1
    Background: Our previous studies in a group of arylpiperazine derivatives of 1,3-dimethyl-3,7-dihydro-purine-2,6-diones, aimed at chemical diversification of the purine-2,6-dione by introduction of hydrophobic substituent in a 7- or 8- position or elongation of the linker length between arylpiperazine and purine core, allowed a selection of potent 5-HT1A, 5-HT2A and 5-HT7 receptor ligands displaying anxiolytic and antidepressant properties. Continuing our research in this field, in the present studies we designed a new series of 8-aminoalkylamino (15-35) and 8-arylpiperazinylpropoxy (36-42) derivatives of 7-substituted 1,3-dimethyl-3,7-dihydropurine-2,6-dione as potential 5-HT1A, 5-HT2A and 5-HT7 receptor ligands with potential psychotropic activity. Methods: Radioligand binding assays were employed for determining the affinity and the selectivity profile of the synthesized compounds for native 5-HT1A, 5-HT2A, and cloned 5-HT6 and 5-HT7 receptors. The functional activity of the selected compounds at 5-HT1A and 5-HT2A receptors was tested in the commonly used in vivo models. Antidepressant and anxiolytic properties were evaluated in the forced swim (FST) and the four-plate test (FPT) in mice, respectively. Results: Among the evaluated series, selected 7-benzyl-8-((4-(4-(3-chlorophenyl)piperazin-1-yl)butyl)amino)-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione (21), a mixed 5-HT1A/5-HT2A/5-HT7 receptor ligand, produced an antidepressant-like effect in FST, and exerted anxiolytic-like activity in FPT. Another pharmacologically evaluated compound 42 (a mixed 5-HT1A/5-HT7 ligand) slightly, but non-significantly attenuated the immobility time of mice in FST and was devoid of activity in FPT. Conclusions: Study revealed advantage of mixed 5-HT1A/5-HT2A/5-HT7 receptor ligands over 5-HT1A/5-HT7 agents to display antidepressant- and anxiolytic-like activity. Modification of arylalkyl/allyl substituent in position 7 of purine-2,6-dione opens possibility for designing new 5-HT ligands with preserved p electron system and lower molecular weight.
  • 7,8-Disubstituted [1,3]-thiazino-[2,3-f]-purine derivatives
    作者:Dušan Hesek、Alfonz Rybár
    DOI:10.1007/bf00810022
    日期:1993.11
    7-Cyanomethyl-8-ethoxycarbonylmethylthio- (3a), 7-cyanomethyl-8-cyanomethylthio- (3b), and 7-ethoxycarbonylmethyl-8-ethoxycarbonylmethylthio-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione (3c) afforded 7-amino-8-ethoxycarbonyl-(5), 7-amino-8-cyano- (6), and 8-ethoxycarbonyl-7-hydroxy-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydro-6H-[1,3]-thiazino-[2,3-f]-purine (7), respectively, on intramolecular Claisen-type condensation.
  • HESEK, DUSAN;, TEGZA MARIAN;RYBAR, ALFONZ;POVAZANEC, FRANTISEK, SYNTHESIS,(1989) N, C. 681-683
    作者:HESEK, DUSAN、, TEGZA MARIAN、RYBAR, ALFONZ、POVAZANEC, FRANTISEK
    DOI:——
    日期:——
查看更多